MIF and hepatocellular carcinoma: Accumulating research has revealed significant upregulation of MIF in various cancer types, including cervical cancer, breast cancer, prostate cancer, hepatoma, neuroblastoma, colorectal cancer, pancreatic cancer and lymphocytic leukemia [18].